A Study to Test How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours)
A Study to Test How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours)
Not yet recruiting · NCT07827144 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Test How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours) | Solid Tumours | Not yet recruiting | Phase 1 | 2026-10-05 | NCT07827144 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AIMEDBIO | 1 |
| Boehringer Ingelheim | 158 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Austin Health | Heidelberg | Australia | 1 |
| Institut Gustave Roussy | Villejuif | France | 54 |
| National Cancer Center Hospital | Tokyo, Chuo-ku | Japan | 15 |
| Samsung Medical Center | Seoul | South Korea | 375 |
| Seoul National University Hospital | Seoul | South Korea | 393 |
| Texas Oncology - Irving | Irving | United States | 1 |